Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Glaxo and SmithKline to merge

Glaxo Wellcome (LSE:GLXO, GLX) and SmithKline Beecham (LSE:SB, SBH) unveiled details of their proposed merger of equals to create Glaxo SmithKline. The combined company, which will keep its corporate headquarters in the U.K. but relocate its operational headquarters

Read the full 389 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers